Trials / Completed
CompletedNCT07145892
Three-dimensional Digital Breast Tomosynthesis Versus Digital Mammography
Three-dimensional Digital Breast Tomosynthesis Versus Digital Mammography: Which Get the Supremacy in Diagnosis of Benign Breast Lesions in Asymptomatic Females
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 255 (actual)
- Sponsor
- The General Authority for Teaching Hospitals and Institutes · Network
- Sex
- Female
- Age
- 30 Years
- Healthy volunteers
- Not accepted
Summary
This study aimed to compare the supremacy of (3D) tomosynthesis versus (2D) digital mammography in the diagnosis of benign breast lesions in asymptomatic females.
Detailed description
Most of the breast lesions are benign, but much concern is given to malignant lesions because breast cancer is the most common malignancy in women. Mammography is the only study for screening in asymptomatic patients, and it is the initial imaging study in the diagnosis of symptomatic patients, with a sensitivity for suspicious lesions of 86% and a specificity of 57%. In recent years, a significant effort has been expended to develop new approaches to breast imaging, one of which is the use of digital breast tomosynthesis (DBT), which is a pseudo three-dimensional digital mammography system that produces a series of thin-section reconstructed images from low-dose X-ray projections at multiple angles.
Conditions
- Three Dimension
- Digital Tomosynthesis
- Digital Mammography
- Diagnosis
- Benign Breast Lesions
- Asymptomatic Females
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Three-dimensional Digital Breast Tomosynthesis | Patients underwent three-dimensional digital breast tomosynthesis. |
| DEVICE | Two-dimensional Digital Mammography | Patients underwent two-dimensional digital mammography |
Timeline
- Start date
- 2024-06-01
- Primary completion
- 2025-05-29
- Completion
- 2025-05-29
- First posted
- 2025-08-28
- Last updated
- 2025-08-28
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT07145892. Inclusion in this directory is not an endorsement.